NM_012071.4:c.6G>T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012071.4(COMMD3):c.6G>T(p.Glu2Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000429 in 1,536,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012071.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 16AN: 149270Hom.: 0 AF XY: 0.0000759 AC XY: 6AN XY: 79022
GnomAD4 exome AF: 0.0000397 AC: 55AN: 1384622Hom.: 0 Cov.: 30 AF XY: 0.0000337 AC XY: 23AN XY: 683202
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.6G>T (p.E2D) alteration is located in exon 1 (coding exon 1) of the COMMD3-BMI1 gene. This alteration results from a G to T substitution at nucleotide position 6, causing the glutamic acid (E) at amino acid position 2 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at